Discover this podcast and so much more

Podcasts are free to enjoy without a subscription. We also offer ebooks, audiobooks, and so much more for just $11.99/month.

Final US presidential debate, FDA approves remdesivir, Intel data hit by pandemic

Final US presidential debate, FDA approves remdesivir, Intel data hit by pandemic

FromFT News Briefing


Final US presidential debate, FDA approves remdesivir, Intel data hit by pandemic

FromFT News Briefing

ratings:
Length:
11 minutes
Released:
Oct 23, 2020
Format:
Podcast episode

Description

Donald Trump and his Democratic challenger, Joe Biden, clashed over issues from the pandemic to foreign policy in their final presidential election debate. Then, the FT’s Demetri Sevastopulo will explain why local races in Texas and around the US could dictate the political make-up of the country for years to come. Plus, Gilead has received the first US regulatory approval for a Covid-19 drug, and Intel reported a decline in data centre revenues and said its earnings fell by nearly a quarter from a year ago due to the pandemic.Donald Trump and Joe Biden clash over coronavirus in final debatehttps://www.ft.com/content/bef48683-9bde-4ac2-8906-797779593b22Gilead secures FDA approval for remdesivir https://www.ft.com/content/07a321de-109b-46aa-99bc-f884e0ed7703 See acast.com/privacy for privacy and opt-out information.
Released:
Oct 23, 2020
Format:
Podcast episode

Titles in the series (100)

A rundown of the most important global business stories you need to know for the coming day, from the newsroom of the Financial Times. Available every weekday morning. See acast.com/privacy for privacy and opt-out information.